Atomwise patented the first deep learning technology for structure-based small molecule drug discovery.
This company has graduated from the startup index, so it is no longer ranked.
Listed
Our AI superplatform explores chemical space for novel molecules, enhancing drug discovery using machine learning to uncover unseen potential.
If a fact is wrong, or you want the profile removed, tell us: we act on every request within 2 business days.